• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller

Professional Introduction to (Azetidin-3-ylmethyl)dimethylamine Dihydrochloride (CAS No. 321890-22-6)

(Azetidin-3-ylmethyl)dimethylamine dihydrochloride is a significant compound in the field of pharmaceutical chemistry, renowned for its versatile applications in drug development and biochemical research. With a CAS number of 321890-22-6, this compound has garnered attention due to its unique structural properties and potential therapeutic benefits. This introduction delves into the compound's chemical characteristics, its role in modern research, and its implications for future pharmaceutical advancements.

The molecular structure of (Azetidin-3-ylmethyl)dimethylamine dihydrochloride consists of an azetidine ring substituted with a methyl group at the 3-position, further functionalized with two dimethylamino groups. This configuration imparts a high degree of reactivity, making it a valuable intermediate in the synthesis of various pharmacologically active agents. The presence of the dihydrochloride salt form enhances its solubility in aqueous solutions, facilitating its use in both in vitro and in vivo experimental settings.

In recent years, there has been a growing interest in exploring the pharmacological potential of (Azetidin-3-ylmethyl)dimethylamine dihydrochloride. Studies have indicated that this compound exhibits promising properties as a modulator of neurotransmitter systems, particularly in the context of central nervous system (CNS) disorders. Its ability to interact with specific receptor targets has led researchers to investigate its potential as an adjunct therapy for conditions such as depression, anxiety, and neurodegenerative diseases. The azetidine core structure is known for its ability to mimic natural amino acids, which could contribute to its efficacy in modulating neural pathways.

One of the most compelling aspects of (Azetidin-3-ylmethyl)dimethylamine dihydrochloride is its role in the development of novel antimicrobial agents. The unique chemical environment created by the azetidine ring and the dimethylamino substituents provides a scaffold that can be modified to target bacterial and fungal pathogens. Recent research has demonstrated that derivatives of this compound exhibit potent activity against multidrug-resistant strains, offering a hopeful solution to the growing challenge of antibiotic resistance. This finding underscores the importance of exploring structurally diverse compounds in the quest for new antimicrobial therapies.

The synthesis of (Azetidin-3-ylmethyl)dimethylamine dihydrochloride involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies have been employed to optimize yield and purity, ensuring that researchers have access to high-quality material for their studies. Techniques such as catalytic hydrogenation and nucleophilic substitution play crucial roles in constructing the desired molecular framework. The dihydrochloride salt form is particularly important as it stabilizes the compound and enhances its handling characteristics.

The application of computational chemistry has further enhanced our understanding of (Azetidin-3-ylmethyl)dimethylamine dihydrochloride. Molecular modeling studies have provided insights into its interactions with biological targets, allowing researchers to predict potential binding affinities and side effects. These computational approaches complement traditional experimental methods, enabling a more efficient discovery process. By integrating both computational and experimental data, scientists can accelerate the development of novel drugs based on this compound.

Current clinical trials are exploring the therapeutic potential of derivatives related to (Azetidin-3-ylmethyl)dimethylamine dihydrochloride. Preliminary results suggest that certain analogs exhibit significant efficacy in animal models of CNS disorders without causing notable side effects. These findings are encouraging and warrant further investigation into human trials. The goal is to develop safe and effective treatments that can address unmet medical needs associated with these conditions.

The environmental impact of synthesizing and using (Azetidin-3-ylmethyl)dimethylamine dihydrochloride is also a consideration in modern pharmaceutical research. Efforts are being made to develop greener synthetic routes that minimize waste and reduce energy consumption. Sustainable practices are increasingly important as the pharmaceutical industry strives to balance innovation with environmental responsibility. By adopting eco-friendly methodologies, researchers can ensure that their work contributes positively to both science and society.

In conclusion, (Azetidin-3-ylmethyl)dimethylamine dihydrochloride (CAS No. 321890-22-6) represents a promising compound with diverse applications in pharmaceutical research and drug development. Its unique chemical structure and pharmacological properties make it a valuable tool for investigating CNS disorders, antimicrobial agents, and other therapeutic areas. As research continues to uncover new possibilities, this compound is poised to play a significant role in shaping the future of medicine.

• 182316-65-0(1,5,9-Triazabicyclo[9.1.1]tridecane)
• 1184963-68-5(2,6-Diazaspiro[3.3]heptane dihydrochloride)
• 321890-34-0((azetidin-3-ylmethyl)dimethylamine)
• 96308-73-5((3-Methylazetidin-3-yl)methanamine dihydrochloride)
• 864350-83-4(methyl[(1-methylazetidin-3-yl)methyl]amine)
• 1087740-50-8(2,6-Diazaspiro[3.3]heptane, (Hydrochloride), hydrate (1:2:2))
• 741287-55-8((azetidin-3-ylmethyl)dimethylamine hydrochloride)
• 936255-80-0(2-(aminomethyl)-N',N'-dimethyl-propane-1,3-diamine;trihydrochloride)
• 6105-72-2((3-amino-2-methylpropyl)dimethylamine)
• 174-77-6(2,6-Diazaspiro[3.3]heptane)